|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7790 USD | +7.01% |
|
+11.29% | -42.30% |
Projected Income Statement: cbdMD, Inc.
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 44.48 | - | 24.16 | 19.48 | 19.19 | 21.2 | 22.69 |
| Change | - | - | - | -19.35% | -1.5% | 10.49% | 7% |
| EBITDA | -18.6 | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - |
| EBIT 1 | -19.62 | - | -5.527 | -1.592 | -0.9098 | -1.468 | -0.54 |
| Change | - | - | - | 71.19% | 42.85% | -61.35% | 63.22% |
| Interest Paid | -0.0289 | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -24.29 | - | -22.94 | -3.7 | -2.041 | -1.465 | -0.54 |
| Change | - | - | - | 83.87% | 44.84% | 28.22% | 63.14% |
| Net income 1 | -25.95 | -70.08 | -26.94 | -7.704 | -2.041 | -1.802 | -0.935 |
| Change | - | -170.08% | 61.56% | 71.4% | 73.51% | 11.71% | 48.11% |
| Announcement Date | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | 12/19/25 | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: cbdMD, Inc.
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Net Debt | -26.2 | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - |
| Announcement Date | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | 12/19/25 | - | - |
Estimates
Cash Flow Forecast: cbdMD, Inc.
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| CAPEX 1 | 1.32 | 0.342 | 0.6887 | 0.2975 | 0.19 | 0.1842 |
| Change | - | -74.09% | 101.36% | -56.79% | -36.14% | -3.08% |
| Free Cash Flow (FCF) 1 | -5.318 | -7.479 | -9.38 | -0.6158 | 5.776 | -4.925 |
| Change | - | -40.63% | -25.42% | 93.44% | 1,038.04% | -185.26% |
| Announcement Date | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | 12/19/25 |
1USD in Million
Estimates
Forecast Financial Ratios: cbdMD, Inc.
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | - | -41.81% | - | - | - | - | - | - |
| EBIT Margin (%) | - | -44.1% | - | -22.88% | -8.17% | -4.74% | -6.92% | -2.38% |
| EBT Margin (%) | - | -54.61% | - | -94.96% | -18.99% | -10.63% | -6.91% | -2.38% |
| Net margin (%) | - | -58.34% | - | -111.53% | -39.54% | -10.63% | -8.5% | -4.12% |
| FCF margin (%) | - | -32.45% | - | - | - | - | - | - |
| FCF / Net Income (%) | - | 55.63% | - | - | - | - | - | - |
Profitability | ||||||||
| ROA | -10.4% | -10.4% | -13.06% | -20.33% | -15.48% | -12.87% | - | - |
| ROE | 21.67% | -25.66% | -104.16% | -113.4% | -67.31% | -44.42% | - | - |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | -0.25x | - | - | - | - |
| Debt / Free cash flow | - | - | - | -3.06x | - | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | - | 0.77% | - | 1.23% | - | - | - | - |
| CAPEX / EBITDA (%) | - | -1.84% | - | - | - | - | - | - |
| CAPEX / FCF (%) | - | -2.37% | - | - | - | - | - | - |
Items per share | ||||||||
| Cash flow per share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| EPS 1 | - | -169.2 | -446.4 | -106.6 | -14.32 | -1.09 | -0.14 | -0.07 |
| Change | - | - | -163.83% | 76.13% | 86.56% | 92.39% | 87.16% | 50% |
| Nbr of stocks (in thousands) | - | 160 | 168 | 357 | 480 | 8,913 | 10,496 | 10,496 |
| Announcement Date | - | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | 12/19/25 | - | - |
1USD
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E ratio | -5.56x | -11.1x |
| PBR | - | - |
| EV / Sales | 0.39x | 0.36x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7790USD
Average target price
2.000USD
Spread / Average Target
+156.74%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- YCBD Stock
- Financials cbdMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
















